Posted by Michael Wonder on 01 Nov 2023
ICER to assess MDMA assisted therapy for post-traumatic stress disorder
1 November 2023 - Report will be subject of New England CEPAC meeting in May 2024; draft scoping document open to public comment until 21 November 2023.
The Institute for Clinical and Economic Review announced today that it will assess the comparative clinical effectiveness and value of methylenedioxymethamphetamine (MDMA) assisted therapy for the treatment of post-traumatic stress disorder.
